Chemotherapy combo boosts survival

Five new studies indicate that adding chemotherapy to current treatments for invasive cervical cancer boosts survival and should become the new standard of care.

References:

Morris, M. In press. Pelvic radiation with concurrent chemotherapy versus pelvic and para-aortic radiation for high-risk cervical cancer: A randomized radiation therapy oncology group clinical trial. New England Journal of Medicine.

Sources:

Mitchell Morris
University of Texas
Anderson Cancer Center
1515 Holcombe Boulevard
Houston, TX 77030

From Science News, Vol. 155, No. 12, March 20, 1999, p. 187. Copyright © 1999, Science Service.

• Home
• Search
• Feedback

• Table of Contents
• Online Archive
• Order Back Issues